CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 7005 result(s)

Sativex for the Management of Multiple Sclerosis Symptoms

Last Updated: September 2, 2005
Result type: Reports

Sativex® is a cannabis-based pharmaceutical product containing ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a 1:1 ratio, delivered in an oromucosal (mouth) spray. It has been approved as adjunctive treatment for neuropathic pain in patients with multiple sclerosis (MS). It is being investigated for the management of other MS sy...

Cholinesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

Last Updated: September 2, 2005
Result type: Reports

Technology Cholinesterase inhibitors (ChEIs): donepezil, galantamine and rivastigmine. Disease Alzheimer’s disease (AD) is a form of dementia. Its most common symptom is memory loss. People with AD may forget simple words, misplace items and become disoriented regarding time and place. In 1991, approximately 5% of individuals older than 65 ye...

Exenatide for the Treatment of Type 2 Diabetes Mellitus

Last Updated: August 30, 2005
Result type: Reports

Exenatide is a glucagon-like peptide-1 agonist. It is being investigated as an add-on therapy for patients with type 2 diabetes mellitus who are taking oral antidiabetic drugs. Evidence indicates that exenatide reduces glycosylated hemoglobin and plasma glucose levels when compared with placebo. Limitations of the therapy inclu...

Sleep Laboratory Investigations: A Review of Patient Referral Guidelines

Last Updated: August 29, 2005
Result type: Reports

Technology Name Examinations performed in sleep laboratories Disease or Condition Conditions include obstructive sleep apnea in adults and in children, other conditions that produce sleep disturbances, respiratory disorders, sudden infant death syndrome, insomnia, depression with insomnia, narcolepsy, parasomnias, restless legs syndrome and p...

Lung Volume Reduction Surgery for Emphysema:Systematic Review of Studies Comparing Different Procedures

Last Updated: August 24, 2005
Result type: Reports

Technology Lung volume reduction surgery (LVRS) using buttressing (reinforcing) or no buttressing; staples or laser; unilateral or bilateral procedures; staged or simultaneous procedures; and median sternotomy (MS) or video-assisted thoracoscopic surgery (VATS). Disease Emphysema is a chronic obstructive pulmonary disease (COPD) that mainly a...

Tenofovir disoproxil fumarate (Viread)

Last Updated: August 11, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Tenofovir disoproxil fumarate
Indications: HIV infection

  • Brand Name: Viread
  • Manufacturer: Gilead Sciences Canada Inc.
  • Project Number: S0040
  • Project Status: Complete
  • Submission Type: Resubmission

Escitalopram oxalate (Cipralex)

Last Updated: August 3, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Escitalopram oxalate
Indications: Depression, Major Depressive Disorder (MDD)

  • Brand Name: Cipralex
  • Manufacturer: Lundbeck Canada Inc.
  • Project Number: S0039
  • Project Status: Withdrawn
  • Submission Type: New

Abacavir/lamivudine (Kivexa)

Last Updated: July 26, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Abacavir/lamivudine
Indications: HIV infection

  • Brand Name: Kivexa
  • Manufacturer: GlaxoSmithKline
  • Project Number: S0038
  • Project Status: Complete
  • Submission Type: New

Erlotinib (Tarceva)

Last Updated: July 19, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Erlotinib
Indications: Cancer, Lung , non-small cell

  • Brand Name: Tarceva
  • Manufacturer: Hoffmann-La Roche Limited
  • Project Number: S0037
  • Project Status: Complete
  • Submission Type: New